Oxidative stress and anxiety: Relationship and cellular pathways

High O2 consumption, modest antioxidant defenses and a lipid-rich constitution make the brain highly vulnerable to redox imbalances. Oxidative damage in the brain causes nervous system impairment. Recently, oxidative stress has also been implicated in depression, anxiety disorders and high anxiety levels. The findings which establish a link between oxidative stress and pathological anxiety have inspired a number of other recent studies focusing on the link between oxidative status and normal anxiety and also on a possible causal relationship between cellular oxidative stress and emotional stress. This review examines the recent discoveries made on the link between oxidative status and normal anxiety levels and the putative role of oxidative stress in genesis of anxiety. We discuss the different opinions and questions that exist in the field and review the methodological approaches that are being used to determine a causal relationship between oxidative and emotional stress

Phytochemical Composition and Antioxidant Capacity of Three Malian Medicinal Plant Parts

This study evaluates the levels of total polyphenolic compounds in three Malian medicinal plants and determines their antioxidant potential. Quantitative and qualitative analysis of polyphenolics contained in plants extracts were carried out by RP-C18 RP–HPLC using UV detector. The antioxidant activity was determined by three tests. They are phosphomolybdenum, DPPH (2,2-diphenyl-1 picrylhydrazyl) and ABTS [2,2′-azino-bis(3-ethylbenzothiazoline-6-sulfonic)] tests. The total phenolic and the total flavonoid contents varied from 200 to 7600 mg 100 g−1 dry weight (dw), expressed as gallic acid equivalents and from 680 to 12 300 mg 100 g−1 dw expressed as catechin equivalents, respectively. The total anthocyanin concentrations expressed as cyanin-3-glycoside equivalent varied from 1670 to 28 388 mg 100 g−1 dw. The antioxidant capacity was measured by determining concentration of a polyphenolic (in mg ml−1) required to quench the free radicals by 50% (IC50) and expressed as vitamin C equivalent antioxidant capacity. The IC50 values were ranked between 2.68 and 8.80 μg ml−1 of a solution of 50% (v/v) methanol in water. The uses of plants are rationalized on the basis of their antioxidant capacity

Chemical Composition and, Cellular Evaluation of the Antioxidant Activity of Desmodium adscendens Leaves

Desmodium adscendens plant is widely used as juice or tea in various parts of the world against a wide range of diseases. This study determines the quality and the quantity of polyphenols, flavonoids, anthocyanins, and tannins in D. adscendens leaves by UV-spectrophotometry and RP-HPLC methods. In addition, the antioxidant capacity of these phenolic compounds is evaluated by ABTS (2,2′-azino-bis(3-ethylbenzothiazoline-6-sulfonic)), DPPH (2,2-diphenyl-1 picrylhydrazyl), and Cellular tests. D. adscendens leaves are mainly composite of flavonoid compounds with 12.8 mg of catechin equivalent (CE)/g dw. The amounts of total polyphenol compounds are 11.1 mg of gallic acid equivalent (GAE)/g dw. The quantity of total anthocyanin and total tannin compounds is not considerable 0.0182 mg CgE/g dw and 0.39 mg CE/g dw, respectively. A direct correlation between phenolic compounds and antioxidant activity is observed (R2 = 0.96). The RP-HPLC analyses reveal that the main phenolic compound identified in the methanol-water extract is quercetrin dihydrat (2.11 mg/mL). According to the results, it is observed that D. adscendens leaves possess a considerable scavenging antioxidant and antiradical capacity, therefore these antioxidant properties might increase the therapeutic value of this medicinal plant

Original Article Phytochemical Composition and Antioxidant Capacity of Three Malian Medicinal Plant Parts

This study evaluates the levels of total polyphenolic compounds in three Malian medicinal plants and determines their antioxidant potential. Quantitative and qualitative analysis of polyphenolics contained in plants extracts were carried out by RP-C18 RP-HPLC using UV detector. The antioxidant activity was determined by three tests. They are phosphomolybdenum, DPPH (2,2-diphenyl-1 picrylhydrazyl) and ABTS [2,2 -azino-bis(3-ethylbenzothiazoline-6-sulfonic)] tests. The total phenolic and the total flavonoid contents varied from 200 to 7600 mg 100 g −1 dry weight (dw), expressed as gallic acid equivalents and from 680 to 12 300 mg 100 g −1 dw expressed as catechin equivalents, respectively. The total anthocyanin concentrations expressed as cyanin-3-glycoside equivalent varied from 1670 to 28 388 mg 100 g −1 dw. The antioxidant capacity was measured by determining concentration of a polyphenolic (in mg ml −1 ) required to quench the free radicals by 50% (IC 50 ) and expressed as vitamin C equivalent antioxidant capacity. The IC 50 values were ranked between 2.68 and 8.80 μg ml −1 of a solution of 50% (v/v) methanol in water. The uses of plants are rationalized on the basis of their antioxidant capacity

EPMA-World Congress 2015: Bonn, Germany. 3-5 September 2015

Table of contents A1 Predictive and prognostic biomarker panel for targeted application of radioembolisation improving individual outcomes in hepatocellular carcinoma Jella-Andrea Abraham, Olga Golubnitschaja A2 Integrated market access approach amplifying value of “Rx-CDx” Ildar Akhmetov A3 Disaster response: an opportunity to improve global healthcare Russell J. Andrews, Leonidas Quintana A4 USA PPPM: proscriptive, profligate, profiteering medicine-good for 1 % wealthy, not for 99 % unhealthy Russell J. Andrews A5 The role of IDO in a murine model of gingivitis: predictive and therapeutic potentials Babak Baban, Jun Yao Liu, Xu Qin, Tailing Wang, Mahmood S. Mozaffari A6 Specific diets for personalised treatment of diabetes type 2 Viktoriia V. Bati, Tamara V. Meleshko, Olga B. Levchuk, Nadiya V. Boyko A7 Towards personalized physiotherapeutic approach Joanna Bauer, Ewa Boerner, Halina Podbielska A8 Cells, animal, SHIME and in silico models for detection and verification of specific biomarkers of non-communicable chronic diseases Alojz Bomba, Viktor O. Petrov, Volodymyr G. Drobnych, Rostyslav V. Bubnov, Oksana M. Bykova, Nadiya V. Boyko A9 INTERACT-chronic care model: Self-treatment by patients with decision support e-Health solution Hans-Peter Brunner-La Rocca, Lutz Fleischhacker, Olga Golubnitschaja, Frank Heemskerk, Thomas Helms, Tiny Jaarsma, Judita Kinkorova, Jan Ramaekers, Peter Ruff, Ivana Schnur, Emilio Vanoli, Jose Verdu A10 PPPM in cardiovascular medicine in 2015 Hans-Peter Brunner-La Rocca A11 Magnetic resonance imaging of nanoparticles in mice, potential for theranostic and contrast media development – pilot results Rostyslav V. Bubnov, Sergiy A. Grabovetskyi, Olena M. Mykhalchenko, Natalia O. Tymoshok, Oleksandr B. Shcherbakov, Igor P. Semeniv, Mykola Y. Spivak A12 Ultrasound diagnosis for diabetic neuropathy - comparative study Rostyslav V. Bubnov, Tetyana V. Ostapenko A13 Ultrasound for stratification patients with diabetic foot ulcers for prevention and personalized treatment - pilot results Rostyslav V. Bubnov, Nazarii M. Kobyliak, Nadiya M. Zholobak, Mykola Ya. Spivak A14 Project ImaGenX – designing and executing a questionnaire on environment and lifestyle risk of breast cancer John Paul Cauchi A15 Genomics – a new structural brand of predictive, preventive and personalized medicine or the new driver as well? Dmitrii Cherepakhin, Marina Bakay, Artem Borovikov, Sergey Suchkov A16 Survey of questionnaires for evaluation of the quality of life in various medical fields Barbara Cieślik, Agnieszka Migasiewicz, Maria-Luiza Podbielska, Markus Pelleter, Agnieszka Giemza, Halina Podbielska A17 Personalized molecular treatment for muscular dystrophies Sebahattin Cirak A18 Secondary mutations in circulating tumour DNA for acquired drug resistance in patients with advanced ALK + NSCLC Marzia Del Re, Paola Bordi, Valentina Citi, Marta Palombi, Carmine Pinto, Marcello Tiseo, Romano Danesi A19 Recombinant species-specific FcεRI alpha proteins for diagnosis of IgE-mediated allergies in dogs, cats and horses Lukas Einhorn, Judit Fazekas, Martina Muhr, Alexandra Schoos, Lucia Panakova, Ina Herrmann, Krisztina Manzano-Szalai, Kumiko Oida, Edda Fiebiger, Josef Singer, Erika Jensen-Jarolim A20 Global methodology for developmental neurotoxicity testing in humans and animals early and chronically exposed to chemical contaminants Arpiné A. Elnar, Nadia Ouamara, Nadiya Boyko, Xavier Coumoul, Jean-Philippe Antignac, Bruno Le Bizec, Gauthier Eppe, Jenny Renaut, Torsten Bonn, Cédric Guignard, Margherita Ferrante, Maria Liusa Chiusano, Salvatore Cuzzocrea, Gerard O'Keeffe, John Cryan, Michelle Bisson, Amina Barakat, Ihsane Hmamouchi, Nasser Zawia, Anumantha Kanthasamy, Glen E. Kisby, Rui Alves, Oscar Villacañas Pérez, Kim Burgard, Peter Spencer, Norbert Bomba, Martin Haranta, Nina Zaitseva, Irina May, Stéphanie Grojean, Mathilde Body-Malapel, Florencia Harari, Raul Harari, Kristina Yeghiazaryan, Olga Golubnitschaja, Vittorio Calabrese, Christophe Nemos, Rachid Soulimani A21 Mental indicators at young people with attributes hypertension and pre-hypertension Maria E. Evsevyeva, Elena A. Mishenko, Zurida V. Kumukova, Evgeniy V. Chudnovsky, Tatyana A. Smirnova A22 On the approaches to the early diagnosis of stress-induced hypertension in young employees of State law enforcement agencies Maria E. Evsevyeva, Ludmila V. Ivanova, Michail V. Eremin, Maria V. Rostovtseva A23 Сentral aortic pressure and indexes of augmentation in young persons in view of risk factors Maria E. Evsevyeva, Michail V. Eremin, Vladimir I. Koshel, Oksana V. Sergeeva, Nadesgda M. Konovalova A24 Breast cancer prediction and prevention: Are reliable biomarkers in horizon? Shantanu Girotra, Olga Golubnitschaja A25 Flammer Syndrome and potential formation of pre-metastatic niches: A multi-centred study on phenotyping, patient stratification, prediction and potential prevention of aggressive breast cancer and metastatic disease Olga Golubnitschaja, Manuel Debald, Walther Kuhn, Kristina Yeghiazaryan, Rostyslav V. Bubnov, Vadym M. Goncharenko, Ulyana Lushchyk, Godfrey Grech, Katarzyna Konieczka A26 Innovative tools for prenatal diagnostics and monitoring: improving individual pregnancy outcomes and health-economy in EU Olga Golubnitschaja, Jan Jaap Erwich, Vincenzo Costigliola, Kristina Yeghiazaryan, Ulrich Gembruch A27 Immunohistochemical assessment of APUD cells in endometriosis Vadym M. Goncharenko, Vasyl O. Beniuk, Olga V. Kalenska, Rostyslav V. Bubnov A28 Updating personalized management algorithm of endometrial hyperplasia in pre-menopause women Vadym M. Goncharenko, Vasyl O. Beniuk, Rostyslav V. Bubnov, Olga Melnychuk A29 The personified treatment approach of polimorbid patients with periodontal inflammatory diseases Irina A. Gorbacheva, Lyudmila Y. Orekhova, Vadim V. Tachalov A30 Ukrainian experience in hybrid war – the challenge to update algorithms for personalized care and early prevention of different military injuries Olena I. Grechanyk, Rizvan Ya. Abdullaiev, Rostyslav V. Bubnov A31 Tear fluid biomarkers: a comparison of tear fluid sampling and storage protocols Suzanne Hagan, Eilidh Martin, Ian Pearce, Katherine Oliver A32 The correlation of dietary habits with gingival problems during menstruation Cenk Haytac, Fariz Salimov, Servin Yoksul, Anatoly A. Kunin, Natalia S. Moiseeva A33 Genomic medicine in a contemporary Spanish population of prostate cancer: our experience Bernardo Herrera-Imbroda, Sergio del Río-González, Maria Fernanda Lara, Antonia Angulo, Francisco Javier Machuca Santa-Cruz A34 Challenges, opportunities and collaborations for personalized medicine applicability in uro-oncological disease Bernardo Herrera-Imbroda, Sergio del Río-González, Maria Fernanda Lara A35 Metabolic hallmarks of cancer as targets for a personalized therapy John Ionescu A36 Influence of genetic polymorphism as a predictor of the development of periodontal disease in patients with gastric ulcer and 12 duodenal ulcer Alfiya Z. Isamulaeva, Anatoly A. Kunin, Shamil Sh. Magomedov, Aida I. Isamulaeva A37 Challenges in diabetic macular edema Tatjana Josifova A38 Overview of the EPMA strategies in laboratory medicine relevant for PPPM Marko Kapalla, Juraj Kubáň, Olga Golubnitschaja, Vincenzo Costigliola A39 EPMA initiative for effective organization of medical travel: European concepts and criteria Vincenzo Costigliola, Marko Kapalla, Juraj Kubáň, Olga Golubnitschaja A40 Design and innovation in e-textiles: implications for PPPM Anthony Kent, Tom Fisher, Tilak Dias A41 Biobank in Pilsen as a member of national node BBMRI_CZ Judita Kinkorová, Ondřej Topolčan A42 Big data in personalized medicine: hype and hope Matthias Kohl A43 The 3P approach as the platform of the European Dentistry Department (DPPPD) Anatoly A. Kunin, Natalia S. Moiseeva A44 The endometrium cytokine patterns for predictive diagnosis of proliferation severity and cancer prevention Andrii I. Kurchenko, Vasyl A. Beniuk, Vadym M. Goncharenko, Rostyslav V. Bubnov, Nadiya V. Boyko, Andriy M. Strokan A45 A monocyte-based in-vitro system for testing individual responses to the implanted material: future for personalized implant construction Julia Kzhyshkowska, Alexandru Gudima, Ksenia S. Stankevich, Victor D. Filimonov4, Harald Klüter, Evgeniya M. Mamontova, Sergei I. Tverdokhlebov A46 Prediction and prevention of adverse health effects by meteorological factors: Biomarker patterns and creation of a device for self-monitoring and integrated care Ulyana B. Lushchyk, Viktor V. Novytskyy, Igor P. Babii, Nadiya G. Lushchyk, Lyudmyla S. Riabets, Ivanna I. Legka A47 Targeting "disease signatures" towards personalized healthcare Mira Marcus-Kalish, Alexis Mitelpunkt, Tal Galili, Neta Shachar, Yoav Benjamini A48 Influence of the skin imperfection on the personal quality of life and possible tools for objective diagnosis Agnieszka Migasiewicz, Markus Pelleter, Joanna Bauer, Ewelina Dereń, Halina Podbielska A49 The new direction in caries prevention based on the ultrastructure of dental hard tissues and filling materials Natalia S. Moiseeva, Anatoly A. Kunin, Dmitry A. Kunin A50 The use of LED radiation in prevention of dental diseases Natalia S. Moiseeva, Yury A. Ippolitov, Dmitry A. Kunin, Alexei N. Morozov, Natalia V. Chirkova, Nakhid T. Aliev A51 Status of endothelial progenitor cells in diabetic nephropathy: predictive and preventive potentials Mahmood S. Mozaffari, Jun Yao Liu, Babak Baban A52 The status of glucocorticoid-induced leucine zipper protein in salivary gland in Sjögren’s syndrome: predictive and personalized treatment potentials Mahmood S. Mozaffari, Jun Yao Liu, Rafik Abdelsayed, Xing-Ming Shi, Babak Baban A53 Maximal aerobic capacity - important quality marker of health Jaroslav Novák, Milan Štork, Václav Zeman A54 The EMPOWER project: laboratory medicine and Horizon 2020 Wytze P. Oosterhuis, Elvar Theodorsson A55 Personality profile manifestations in patient’s attitude to oral care and adherence to doctor’s prescriptions Lyudmila Y. Orekhova, Tatyana V. Kudryavtseva, Elena R. Isaeva, Vadim V. Tachalov, Ekaterina S. Loboda A56 Results of an European survey on personalized medicine addressed to directions of laboratory medicine Mario Pazzagli, Francesca Malentacchi, Irene Mancini, Ivan Brandslund, Pieter Vermeersch, Matthias Schwab, Janja Marc, Ron H.N. van Schaik, Gerard Siest, Elvar Theodorsson, Chiara Di Resta A57 MCI or early dementia predictive speech based diagnosis techniques Matus Pleva, Jozef Juhar A58 Personalized speech based mobile application for eHealth Matus Pleva, Jozef Juhar A59 Circulating tumor cell-free DNA as the biomarker in the management of cancer patients Jiří Polívka jr., Filip Janků, Martin Pešta, Jan Doležal, Milena Králíčková, Jiří Polívka A60 Complex stroke care – educational programme in Stroke Centre University Hospital Plzen Jiří Polívka, Alena Lukešová, Nina Müllerová, Petr Ševčík, Vladimír Rohan A61 Sleep apnea and sleep fragmentation contribute to brain aging Kneginja Richter, Lence Miloseva, Günter Niklewski A62 Personalised approach for sleep disturbances in shift workers Kneginja Richter, Jens Acker, Guenter Niklewski A63 Medical travel and innovative PPPM clusters: new concept of integration Olga Safonicheva, Vincenzo Costigliola A64 Medical travel and women health Olga Safonicheva A65 Continuity of generations in the training of specialists in the field of reconstructive microsurgery Maxim Sautin, Janna Sinelnikova, Sergey Suchkov A66 Telemonitoring of stroke patients – empirical evidence of individual risk management results from an observational study in Germany Songül Secer, Stephan von Bandemer A67 Women’s increasing breast cancer risk with n-6 fatty acid intake explained by estrogen-fatty acid interactive effect on DNA damage: implications for gender-specific nutrition within personalized medicine Niva Shapira A68 Cytobacterioscopy of the gingival crevicular fluid as a method for preventive diagnosis of periodontal diseases Aleksandr Shcherbakov, Anatoly A. Kunin, Natalia S. Moiseeva A69 Use of specially treated composites in dentistry to avoid violations of aesthetics Bogdan R. Shumilovich, Zhanna Lipkind, Yulia Vorobieva, Dmitry A. Kunin, Anastasiia V. Sudareva A70 National eHealth system – platform for preventive, predictive and personalized diabetes care Ivica Smokovski, Tatjana Milenkovic A72 The common energy levels of Prof. Szent-Györgyi, the intrinsic chemistry of melanin, and the muscle physiopathology. Implications in the context of Preventive, Predictive, and Personalized Medicine Arturo Solís-Herrera, María del Carmen Arias-Esparza, Sergey Suchkov A73 Plurality and individuality of hepatocellular carcinoma: PPPM perspectives Krishna Chander Sridhar, Olga Golubnitschaja A74 Strategic aspects of higher medical education reforms to secure newer educational platforms for getting biopharma professionals matures Maria Studneva, Sihong Song, James Creeden, Мark Мandrik, Sergey Suchkov A75 Overview of the strategies and activities of the European Federation of Clinical Chemistry and Laboratory Medicine, (EFLM) Elvar Theodorsson, EFLM A76 New spectroscopic techniques for point of care label free diagnostics Syed A. M. Tofail A77 Tumor markers for personalized medicine and oncology - the role of Laboratory Medicine Ondřej Topolčan, Judita Kinkorová, Ondřej Fiala, Marie Karlíková, Šárka Svobodová, Radek Kučera, Radka Fuchsová, Vladislav Třeška, Václav Šimánek, Ladislav Pecen, Jan Šoupal, Štěpán Svačina2 A78 Modern medical terminology (MMT) as a driver of the global educational reforms Evgeniya Tretyak, Maria Studneva, Sergey Suchkov A79 Juvenile hypertension; the relevance of novel predictive, preventive and personalized assessment of its determinants Francesca M. Trovato, G. Fabio Martines, Daniela Brischetto, Daniela Catalano, Giuseppe Musumeci, Guglielmo M. Trovato A80 Proteomarkers Biotech George Th. Tsangaris, Athanasios K. Anagnostopoulos A81 Proteomics and mass spectrometry based non-invasive prenatal testing of fetal health and pregnancy complications George Th. Tsangaris, Athanasios K. Anagnostopoulos A82 Integrated Ecosystem for an Integrated Care model for Heart Failure (HF) patients including related comorbidities (ZENITH) José Verdú, German Gutiérrez, Jordi Rovira, Marta Martinez, Lutz Fleischhacker, Donna Green, Arthur Garson, Elena Tamburini, Stefano Cuomo, Juan Martinez-Leon, Teresa Abrisqueta, Hans-Peter Brunner-La Rocca, Tiny Jaarsma, Teresa Arredondo, Cecilia Vera, Giuseppe Fico, Olga Golubnitschaja, Fernando Arribas, Martina Onderco, Isabel Vara, on behalf of ZENITH consortium A83 Predictive, preventive and personalized medicine in diabetes onset and complication (MOSAIC project) José Verdú, Francesco Sambo, Barbara Di Camillo, Claudio Cobelli, Andrea Facchinetti, Giuseppe Fico, Riccardo Bellazzi, Lucia Sacchi, Arianna Dagliati, Daniele Segnani, Valentina Tibollo, Manuel Ottaviano, Rafael Gabriel, Leif Groop, Jacqueline Postma, Antonio Martinez, Liisa Hakaste, Tiinamaija Tuomi, Konstantia Zarkogianni, on behalf of MOSAIC consortium A84 Possibilities for personalized therapy of diabetes using in vitro screening of insulin and oral hypoglycemic agents Igor Volchek, Nina Pototskaya, Andrey Petrov A85 The innovative technology for personalized therapy of human diseases based on in vitro drug screening Igor Volchek, Nadezhda Pototskaya, Andrey Petrov A86 Bone destruction and temporomandibular joint: predictive markers, pathogenetic aspects and quality of life Ülle Voog-Oras, Oksana Jagur, Edvitar Leibur, Priit Niibo, Triin Jagomägi, Minh Son Nguyen, Chris Pruunsild, Dagmar Piikov, Mare Saag A87 Sub-optimal health management – global vision for concepts in medical travel Wei Wang A88 Sub-optimal health management: synergic PPPM-TCAM approach Wei Wang A89 Innovative technologies for minimal invasive diagnostics Andreas Weinhäusel, Walter Pulverer, Matthias Wielscher, Manuela Hofner, Christa Noehammer, Regina Soldo, Peter Hettegger, Istvan Gyurjan, Ronald Kulovics, Silvia Schönthaler, Gabriel Beikircher, Albert Kriegner, Stephan Pabinger, Klemens Vierlinger A90 Rare disease diobanks for personalized medicine Ayşe Yüzbaşıoğlu, Meral Özgüç, Member of EuroBioBank - European Network of DNA, Cell and Tissue Banks for Rare Disease

Recherche et évaluation de l'activité biologique des substances végétales sur le S.N.C. chez la souris, in vivo et vis-à-vis des récepteurs cholinergiques, histaminergiques et opoïdes, in vitro, au niveau du duodenum de rat et de l'iléon de cobaye

A bibliography study permetted us to select 8 species, Melissa officinalis, Passiflora incarnata, Euphorbia hirta, Eschscholtzia californica and Fagarazanthoxyloïds for their sedative, anxiolytic and analgesic effects ; Annona reticulatla, Peumus boldus and Fumaria officinalis for their antistaminic and antispasmodic effects. Sedative, anxiolytic and analgesic thera peutic indications of Melissa officinalis, Passiflora incarnata Euphorbia hirta, Eschscholtzia californica and Fagara Zanthoxyloïdes have been scientifically confirmed by pharmacological investigation in vivo in the mouse. Antispasmodical effects of Melissa officinalis, Peumus boldus, Annona reticulatla and Fumaria officinalis have been confirmed by pharmacological tests in vivo and in vitro for. Several obtained from Melissa officinalis'extract or the pure natural substances contained in passiflora incarnata did not allowed to find the sedative and anxiolytic properties observed with crude extracts. Sedative properties of 4 plants were not related to antihistaminical effects demonstrated wich isolated guinea-pig ileum. The effect of plant extracts with analgesic properties demonstrated in vivo have been tested in vitro in guinea-pig ileum towards opioïd receptors. Thus, Euphorbia hirta was the single plant which bind with opioïd receptors. Eschscholtzia californica, Fagara zanthoxyloides and Melissa officinalis'extracts are probably not related with opioïd receptors wich probably not be involved in the mechanism of action of actio of their analgesic activityUne étude bibliographique nous a permis de répertorier 8 espèces, Melissa officinalis, Passiflora incarnata, Euphorbia hirta, Eschscholtzia californica et Fagara zanthoxyloides pour leurs effets sédatifs, anxiolytiques et analgésiques ; Annona reticulatla, Peumus boldus et Fumaria officinalis pour leurs effets antihistaminique et antispasmodiques. Les effets sédatifs, anxiolytiques et analgésiques mentionnés par la tradition ont été confirmés scientifiquement par des tests in vivo pour Melissa officinalis, Passiflora inacarnata, Euphorbia hirta, Eschscholtzia californica et Fagara zanthoxyloides alors que les effets antispasmodiques ont été confirmés par des tests in vivo et in vitro, pour Melissa officinalis, Peumus boldus, Annona reticulata et Fumaria officinalis. Le fractionnement pour la recherche du support d'activité sédative et anxiolytique de M. officinalis et P. incarnata n'a pas permis d'identifier un principe actif, l'activité ne se trouve qu'au niveau des extraits totaux. Aucune des plantes sédatives testées n'a manifesté un effet antihistaminique sur les tests in vitro. Il a été mis en évidence, à l'aide de tests in vitro, l'effet d'extraits végétaux à propriété analgésique vis-à-vis des récepteurs opiacés sur l'iléon isolé de cobaye, ainsi l'Euphorbia hirta était la seule plante qui s'apparentait à la morphine quant à son activité analgésique des extraits d'Eschscholtzia californica, Fagara zanthoxyloides et Melissa officinalis ne se fait probablement pas via les récepteurs opioïde

Recherche et evaluation de l'activite biologique des substances vegetales sur le S.N.C. Chez la souris, in vivo et vis-a-vis des recepteurs cholinergiques, histaminergiques et opoides, in vitro, au niveau du duodenum de rat et de l'ileon de cobaye

SIGLEAvailable from INIST (FR), Document Supply Service, under shelf-number : TD 20407 / INIST-CNRS - Institut de l'Information Scientifique et TechniqueFRFranc

Etude de la corrélation anxiété / statut oxydatif des granulocytes chez la souris et évaluation des effets antioxydants . neuroactifs des polyphénols extraits de Prunus domestica L

Au cours de cette étude, une corrélation statistiquement significative entre le niveau d anxiété et le statut oxydatif périphérique a été mise en évidence. En effet, plus le niveau d anxiété augmente plus le niveau intracellulaire des espèces réactives de l oxygène (ERO) des granulocytes est élevé. Les résultats enregistrés ont montré que les granulocytes du sang des souris anxieuses sont sujets à des dommages oxydatifs qui entraînent leurs dysfonctionnements. Ces résultats mettent en évidence l impact du stress anxiogène sur le statut oxydatif et sur l accumulation des ERO intracellulaires qui est un facteur étiologique essentiel. En outre, nous avons trouvé que l acide chlorogénique contenu dans des variétés de prunes dont la mirabelle permet la protection des granulocytes contre le stress oxydant et possède des propriétés anxiolytiques. Le potentiel antiradicalaire de sept variétés de prunes françaises dont la mirabelle a été comparativement évalué par le test ABTS. L effet protecteur de ces prunes sur les granulocytes du sang contre le stress oxydant a été évalué en comparaison au pouvoir protecteur de la vitamine C. La présente étude a montré que les polyphénols sont les supports majeurs de l activité antioxydante des prunes et souligne l intérêt préventif de la consommation des prunes dans l apparition de plusieurs troubles liés au stress oxydant. Le profil chimique des principaux polyphénols des prunes a été déterminé par CLHP et révèle que l acide néochlorogénique est le polyphénol majoritaire. Notre méthode de travail à partir des prunes a permis d étendre ce protocole à la quantification des phénols totaux, des flavonoïdes totaux et de l activité antioxydante totale de plusieurs autres agroressources. Ainsi, l effet protecteur du fruit du Momordica charantia L. et des feuilles du Desmodium adscendens L. contre le stress oxydant des granulocytes a été révélé, ce qui augmente la valeur thérapeutique de ces plantes.In this study, the linear and significant correlation between level of anxiety and peripheral oxidative status has been established. Indeed, the more the level of anxiety increases the more the intracellular level of reactive oxygen species of granulocytes is elevated. Our findings showed that the blood granulocytes of anxious mice may be more prone to oxidative damages altering their functions. These results highlighted the impact of anxiogen stress on the cellular oxidative status, and on the accumulation of intracellular ROS which is an essential etiologic factor. We have also found that chlorogenic acid protected granulocytes from oxidative stress, and possess anxiolytic properties. The antiradical power of seven varieties of French plums including the Mirabelle was comparatively evaluated in this study using ABTS test. Moreover, the protective effect of these plums on freshly isolated granulocytes from oxidative stress was also investigated in comparison with the vitamin C. Our results showed that polyphenols were the major contributor in the antioxidant activity exhibited by plums, and emphasize the preventive advantage of plum consummation from diseases linked to oxidative stress. The chemical profile permitted to reveal that neochlorogenic acid was the predominant polyphenolic in tested plums. The previsiouly protocol has been extended to some plants to quantify total phenolics, total flavonoids and total antioxidant activity. The protective effect of Momordica charantia L. fruit and of Desmodium adscendens L. leaves on granulocytes from oxidative stress has been highlighted, which gives to these plants an additional therapeutic value.METZ-SCD (574632105) / SudocSudocFranceF

L'anxiété trait et son lien avec l'expression des sous-unités des récepteurs (GABAA, 5-HT1A, -opioïdes et x1-adrénérgiques) et des marqueurs du stress oxydatif au niveau du SNC (neurones et cellules gliales) et au niveau périphérique (immunité cellulaire et humorale) (évaluation des effets de substances naturelles à potentiel cytoprotecteur)

Au cours de cette étude, l expression des gènes codants de quatre sous types de récepteurs centraux (GABAA, 5-HT1A, m-opioïdes et a1-adrénergiques) impliqués dans la modulation de l anxiété a été évaluée. L impact de l anxiété trait sur les réponses immunitaires cellulaire et humorale et sur le niveau du statut oxydatif au niveau du SNC (neurones et cellules gliales) et au niveau périphérique (lymphocytes, granulocytes et monocytes) a été mis en évidence. En même temps, l effet de l anxiété trait couplée au modèle de stress expérimental anxiogène par contention, sur les réponses immunitaires cellulaire et humorale a été évalué. En effet, le niveau élevé d anxiété induit d une part, un effet dépressif significatif sur l immunité cellulaire (lymphocytes totaux, TCD4+ et TCD8+) et humorale (IgA et IgE) et d autre part, une augmentation significative du niveau intracellulaire des espèces réactives de l oxygène (ERO) des neurones et des cellules gliales au niveau du cortex cérébral, du cervelet et de l hippocampe et des granulocytes, des lymphocytes et des monocytes au niveau périphérique. De la même manière, l anxiété trait couplée au stress aigu et chronique par contention a provoqué une dépression de certains paramètres de l immunité cellulaire (lymphocytes totaux, TCD4+, TCD8+ et NK) et humorale (IgA, E et G) et une stimulation des autres paramètres (granulocytes et monocytes). Ces travaux ont permis ainsi de valider scientifiquement le caractère anxiogène du modèle du stress par contention, d établir de manière valide et reproductible le lien et la corrélation entre le niveau élevé d anxiété chez des animaux et leur statut oxydatif inducteur d une cytotoxicité ainsi que le rôle de l expression des gènes codants de 4 sous types de récepteurs dans l expression de cette anxiété élevée et d un statut oxydatif important au niveau des cellules périphériques du système immunitaire et des neurones et cellules gliales au niveau central.In this study, genes expression from four central receptors (GABAA, 5-HT1A, m-opioïdes and a1-adrenergic) involved in the modulation of anxiety was assessed. The impact of anxiety on the cellular and humoral immunity and on the oxidative status at the SNC (neurons and glial cells) and peripheral (lymphocytes, granulocytes and monocytes) level was highlighted. At the same time, the effect of anxiety coupled with an anxiogenic restraint stress, on the cellular and humoral immunity was also evaluated. Indeed, the high level of anxiety induced firstly, a significant depressive effect on cellular (total lymphocytes, TCD4+ and TCD8+) and humoral (IgA and IgE) immunity, and secondly, a significant increase of the level of intracellular reactive oxygen species (ROS) of neurons and glial cells in the cerebral cortex, the cerebellum and the hippocampus and in the peripheral blood granulocytes, monocytes and lymphocytes. In the same way, the anxiety coupled to acute and chronic restraint stress provoked, a depression of some parameters of cellular (total lymphocytes, TCD4+, TCD8+ and NK) and humoral (IgA, E and G) immunity, and a stimulation of others (granulocytes and monocytes). These works thus made it possible to validate scientifically the anxiogenic character of the model of restraint stress, to establish in a valid and reproducible way the bond and the correlation between the high level of anxiety in animals and their oxidative status inductive of a cytotoxicity as well as the role of the expression of coding genes of 4 receptors in the expression of this high anxiety and of a significant oxidative status at the level of the peripheral cells of the immune system and the neurons and glial cells at the central levelMETZ-SCD (574632105) / SudocSudocFranceF